Greenstreet Yvonne (CIK 1446125) reported 134 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-06). Recent activity: Sell ALNY (135 shares), Sell ALNY (129 shares), Sell ALNY (274 shares), Sell ALNY (368 shares), Sell ALNY (444 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 135 | $43,069 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 129 | $41,281 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 274 | $87,902 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 368 | $118,430 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 444 | $143,416 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 973 | $315,096 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 345 | $112,084 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 265 | $86,303 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 1,669 | $545,446 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 200 | $64,724 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 382 | $124,016 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 1,098 | $357,542 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Buy | 13,844 | $0 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 1,399 | $458,410 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 424 | $139,373 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 722 | $238,051 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 346 | $114,474 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 399 | $132,440 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 160 | $53,222 |
| 2026-03-02 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Buy | 5,921 | $0 |
| 2026-02-17 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Buy | 14,209 | $0 |
| 2026-02-17 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 6,958 | $2.2M |
| 2026-01-14 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Buy | 19,003 | $0 |
| 2026-01-14 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 247 | $87,426 |
| 2026-01-14 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Chief Executive Officer | Sell | 269 | $95,538 |
Source: SEC Form 4 filings · as of 2026-03-06